Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.
We are in the process of aggregating Alnylam Pharmaceuticals Environment data. Want to contribute? let us know and we will work to get this profile updated.
Social KPIs* data from 2020
Number of Female Employees
Percent of Female Employees in Management
Number of Female Employees in Management
Minorities in Workforce
Number of Minorities in Management
Gender Pay Ratio
Minority Pay Ratio
Recordable Incident Rate
Governance KPIs* data from 2020
CEO Pay Ratio
Number of Women on the Board
How ESG Agencies Rate Alnylam Pharmaceuticals
Refinitv scores are based on publicly-reported data, and consider ten key categories across ESG. The ESG pillar scores are a relative sum of the category weights and vary per industry for the 'E' and 'S' pillars. For 'G', the weights remain the same across all industries. The higher the score, the better.
S&P Global ESG Scores capture the nuances and differences of policies and programs and in-depth ESG information by directly engaging with companies and conducting independent research. Scores range from 0-100. The higher the score the better.
Sustainalytics assesses business risk driven by ESG issues. The rating combines an assessment of a company’s exposure to industry specific ESG issues with how well the company is managing those issues. The final scores are a measure of unmanaged risk on an absolute scale of 0-100. In this case, the lower the score the better.
ISS Governance Scores rate the quality of corporate governance for companies. Scores indicate rank relative to index or region. A score of 1 indicates lower governance risk, while a 10 indicates higher governance risk. In this case, the lower the better.
The MSCI ESG Rating is designed to measure a company’s resilience to ESG risks. They use a rules-based methodology to identify industry leaders and laggards according to their exposure to ESG risks and how well they manage those risks relative to peers. Their ESG Ratings range from leader (AAA, AA), average (A, BBB, BB) to laggard (B, CCC).